Clinical trial
Predictive fActors for toleraNce to Taxane Based CHemotherapy In Older adultS Affected by mEtastatic Prostate Cancer, a Prospective Observational Study (ANCHISES)
NCT05471427 is registered in ClinicalTrials.gov with Azienda Ospedaliero-Universitaria Careggi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictive fActors for toleraNce to Taxane Based CHemotherapy In Older adultS Affected by mEtastatic Prostate Cancer, a Prospective Observational Study (ANCHISES)
- Lead sponsor
- Azienda Ospedaliero-Universitaria Careggi
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2020
- Completion date
- July 1, 2022
- Enrollment
- 118 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
elderly patients, metastatic prostate cancer